In vivo antibacterial activities of sanfetrinem cilexetil, a new oral tricyclic antibiotic

被引：17

作者：

Tamura, S ^{[1
]}

Miyazaki, S ^{[1
]}

Tateda, K ^{[1
]}

Ohno, A ^{[1
]}

Ishii, Y ^{[1
]}

Matsumoto, T ^{[1
]}

Furuya, N ^{[1
]}

Yamaguchi, K ^{[1
]}

机构：

[1] Toho Univ, Sch Med, Dept Microbiol, Tokyo 143, Japan

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1998年 / 42卷 / 07期

关键词：

D O I：

10.1128/AAC.42.7.1858

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The in vivo antibacterial activities of a new oral trinem, sanfetrinem cilexetil (a prodrug of sanfetrinem), were evaluated in comparison with those of cefdinir and amoxicillin. Sanfetrinem cilexetil showed potent efficacy against experimental murine septicemia caused by Staphylococcus aureus, Streptococcus pyogenes, and Escherichia coli and against murine respiratory infections caused by Streptococcus pneumoniae. Likewise, in murine models of respiratory infection by penicillin-susceptible and penicillin-resistant S. pneumoniae, sanfetrinem cilexetil was more effective than amoxicillin in reducing the number of bacteria in infected lungs. These results were reflected in its potent in vitro activity and high levels in plasma.

引用

页码：1858 / 1861

页数：4

共 50 条

[1] In vitro and in vivo antibacterial activities of DW286, a new fluoronaphthyridone antibiotic
Yun, HJ
Min, YH
Lim, JA
Kang, JW
Kim, SY
Kim, MJ
Jeong, JH
Choi, YJ
Kwon, HJ
Jung, YH
Shim, MJ
Choi, EC
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (09) : 3071 - 3074
[2] In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem
Yamaguchi, K
Domon, H
Miyazaki, S
Tateda, K
Ohno, A
Ishii, K
Matsumoto, T
Furuya, N
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) : 555 - 563
[3] Sanfetrinem, an oral (3-lactam antibiotic repurposed for the treatment of tuberculosis
Ramon-Garcia, Santiago
del Rio, Ruben Gonzalez
Arenaz-Callao, Maria Pilar
Boshoff, Helena I.
Rullas, Joaquin
Anca, Sara
Izquierdo, Monica Cacho
de Francisco, Esther Porras
Herran, Esther Perez
Santos-Villarejo, Angel
Mendoza-Losana, Alfonso
Ferrer-Bazaga, Santiago
Thompson, Charles J.
Aguirre, David Barros
Bates, Robert H.
DRUG RESISTANCE UPDATES, 2025, 80
[4] In vitro and in vivo antibacterial activities of the tricyclic ketolide TE-802 and its analogs
Ono, T
Kashimura, M
Suzuki, K
Oyauchi, R
Miyachi, J
Ikuta, H
Kawauchi, H
Akashi, T
Asaka, T
Morimoto, S
JOURNAL OF ANTIBIOTICS, 2004, 57 (08): : 518 - 527
[5] In Vivo Antibacterial Activity of Vertilmicin, a New Aminoglycoside Antibiotic
You, Xue-Fu
Li, Cong-Ran
Yang, Xin-Yi
Yuan, Min
Zhang, Wei-Xin
Lou, Ren-Hui
Wang, Yue-Ming
Li, Guo-Qing
Chen, Hui-Zhen
Song, Dan-Qing
Sun, Cheng-Hang
Cen, Shan
Yu, Li-Yan
Zhao, Li-Xun
Jiang, Jian-Dong
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (10) : 4525 - 4528
[6] In vivo antibacterial activity of chinfloxacin, a new fluoroquinolone antibiotic
Li, Guo-Qing
Bai, Xiao-Gang
Li, Cong-Ran
Yang, Xin-Yi
Hu, Xin-Xin
Yuan, Min
Zhang, Wei-Xin
Lou, Ren-Hui
Guo, Hui-Yuan
Jiang, Jian-Dong
You, Xue-Fu
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (04) : 955 - 961
[7] IN-VITRO AND IN-VIVO ANTIBACTERIAL ACTIVITIES OF S-1090, A NEW ORAL CEPHALOSPORIN
TSUJI, M
ISHII, Y
OHNO, A
MIYAZAKI, S
YAMAGUCHI, K
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (11) : 2544 - 2551
[8] In-vitro and in-vivo antibacterial activities of CS-834, a new oral carbapenem
Sakagawa, E
Otsuki, M
Ou, T
Nishino, T
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (04) : 427 - 437
[9] INVITRO AND INVIVO ANTIBACTERIAL ACTIVITIES OF MEROPENEM, A NEW CARBAPENEM ANTIBIOTIC
HARABE, E
KAWAI, Y
KANAZAWA, K
OTSUKI, M
NISHINO, T
DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1992, 18 (02) : 37 - 46
[10] PEG-grafted liposomes for enhanced antibacterial and antibiotic activities: An in vivo study
Alavi, Seyed Ebrahim
Esfahani, Maedeh Koohi Moftakhari
Raza, Aun
Adelnia, Hossein
Shahmabadi, Hasan Ebrahimi
NANOIMPACT, 2022, 25

← 1 2 3 4 5 →